Max Herrmann News Today

Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript September 21, 2023 Valneva SE misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.36. Operator: Good day, and thank you for standing by. Welcome to the Valneva Half Year 2023 Financial Results Call and Webcast. [Operator Instructions] Please note that today’s conference is being […]

David Livingstone raises alarm over increasing reliance on foreign investors

Ergomed founder and executive chairman Miroslav Reljanovics (pictured) stake in the biotech firm is currently valued at £123m.

Ergomed founder and executive chairman Miroslav Reljanovics (pictured) stake in the biotech firm is currently valued at £123m.

BioPharma

Shares in UK pharmaceutical company Hikma rose by the most in 10 months on Thursday, hitting an 18-month high, following news of tornado damage to a U.S. facility owned by competitor Pfizer, which...

Analysts declare Pfizer as largest supplier in US injectables market and Hikma as second-largest

Despite the cost-of-living crisis, the petcare market seems relatively robust and Dechras pipeline is strong. Buy on this weakness.

Despite the cost-of-living crisis, the petcare market seems relatively robust and Dechras pipeline is strong. Buy on this weakness.

BioPharma